Predictors of symptom experience in Korean patients with cancer undergoing chemotherapy

Hee Sun Kim, Euigeum Oh, Hyangkyu Lee, Soo Hyun Kim, Hyun Kyung Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: This study aimed to investigate symptom experience and identify the predictors of symptom experience in cancer patients undergoing chemotherapy. Method: This study was a cross-sectional and descriptive design. A total of 167 participants were recruited from the outpatient department of a university hospital in South Korea. Symptom experience (symptom prevalence, severity, and interference with daily activities), physiological factors (absolute neutrophil count, hemoglobin), psychological factors (depression, fighting spirit), and a situational factor (social support), based on the Theory of Unpleasant Symptoms, were measured. Descriptive statistics and multiple regression analyses were performed. Results: Symptom prevalence ranged from 74.3% to 98.8% of patients. The five most severe symptoms were fatigue, numbness/tingling, dry mouth, sleep disturbance, and drowsiness. General activity and work were the most affected areas of daily life. Symptom experience was significantly related to hemoglobin, depression, fighting spirit, and social support. In the multiple regression analysis, higher level of depression and lung cancer accounted for 20.2% of the variance in symptom severity. Higher level of depression, lower level of fighting spirit and third or fourth-line chemotherapy accounted for 31.0% of the variance in symptom interference. Conclusions: Attention is drawn to developing a comprehensive approach which considers relevant physiological, psychological and social factors in assessment and management of concurrent symptoms in cancer patients undergoing chemotherapy. Health care professionals need to play a key role in helping patients deal with depressive mood and promote fighting spirit, particularly in patients with lung cancer or patients treated with higher-line chemotherapy, for controlling their symptom experience.

Original languageEnglish
Pages (from-to)644-653
Number of pages10
JournalEuropean Journal of Oncology Nursing
Volume19
Issue number6
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Drug Therapy
Depression
Neoplasms
Social Support
Lung Neoplasms
Hemoglobins
Regression Analysis
Psychology
Republic of Korea
Hypesthesia
Sleep Stages
Fatigue
Mouth
Sleep
Neutrophils
Outpatients
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Oncology(nursing)

Cite this

@article{f1438c50167a4badacf2e8e19cb1fd3b,
title = "Predictors of symptom experience in Korean patients with cancer undergoing chemotherapy",
abstract = "Purpose: This study aimed to investigate symptom experience and identify the predictors of symptom experience in cancer patients undergoing chemotherapy. Method: This study was a cross-sectional and descriptive design. A total of 167 participants were recruited from the outpatient department of a university hospital in South Korea. Symptom experience (symptom prevalence, severity, and interference with daily activities), physiological factors (absolute neutrophil count, hemoglobin), psychological factors (depression, fighting spirit), and a situational factor (social support), based on the Theory of Unpleasant Symptoms, were measured. Descriptive statistics and multiple regression analyses were performed. Results: Symptom prevalence ranged from 74.3{\%} to 98.8{\%} of patients. The five most severe symptoms were fatigue, numbness/tingling, dry mouth, sleep disturbance, and drowsiness. General activity and work were the most affected areas of daily life. Symptom experience was significantly related to hemoglobin, depression, fighting spirit, and social support. In the multiple regression analysis, higher level of depression and lung cancer accounted for 20.2{\%} of the variance in symptom severity. Higher level of depression, lower level of fighting spirit and third or fourth-line chemotherapy accounted for 31.0{\%} of the variance in symptom interference. Conclusions: Attention is drawn to developing a comprehensive approach which considers relevant physiological, psychological and social factors in assessment and management of concurrent symptoms in cancer patients undergoing chemotherapy. Health care professionals need to play a key role in helping patients deal with depressive mood and promote fighting spirit, particularly in patients with lung cancer or patients treated with higher-line chemotherapy, for controlling their symptom experience.",
author = "Kim, {Hee Sun} and Euigeum Oh and Hyangkyu Lee and Kim, {Soo Hyun} and Kim, {Hyun Kyung}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.ejon.2015.04.003",
language = "English",
volume = "19",
pages = "644--653",
journal = "European Journal of Oncology Nursing",
issn = "1462-3889",
publisher = "Churchill Livingstone",
number = "6",

}

Predictors of symptom experience in Korean patients with cancer undergoing chemotherapy. / Kim, Hee Sun; Oh, Euigeum; Lee, Hyangkyu; Kim, Soo Hyun; Kim, Hyun Kyung.

In: European Journal of Oncology Nursing, Vol. 19, No. 6, 01.12.2015, p. 644-653.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Predictors of symptom experience in Korean patients with cancer undergoing chemotherapy

AU - Kim, Hee Sun

AU - Oh, Euigeum

AU - Lee, Hyangkyu

AU - Kim, Soo Hyun

AU - Kim, Hyun Kyung

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Purpose: This study aimed to investigate symptom experience and identify the predictors of symptom experience in cancer patients undergoing chemotherapy. Method: This study was a cross-sectional and descriptive design. A total of 167 participants were recruited from the outpatient department of a university hospital in South Korea. Symptom experience (symptom prevalence, severity, and interference with daily activities), physiological factors (absolute neutrophil count, hemoglobin), psychological factors (depression, fighting spirit), and a situational factor (social support), based on the Theory of Unpleasant Symptoms, were measured. Descriptive statistics and multiple regression analyses were performed. Results: Symptom prevalence ranged from 74.3% to 98.8% of patients. The five most severe symptoms were fatigue, numbness/tingling, dry mouth, sleep disturbance, and drowsiness. General activity and work were the most affected areas of daily life. Symptom experience was significantly related to hemoglobin, depression, fighting spirit, and social support. In the multiple regression analysis, higher level of depression and lung cancer accounted for 20.2% of the variance in symptom severity. Higher level of depression, lower level of fighting spirit and third or fourth-line chemotherapy accounted for 31.0% of the variance in symptom interference. Conclusions: Attention is drawn to developing a comprehensive approach which considers relevant physiological, psychological and social factors in assessment and management of concurrent symptoms in cancer patients undergoing chemotherapy. Health care professionals need to play a key role in helping patients deal with depressive mood and promote fighting spirit, particularly in patients with lung cancer or patients treated with higher-line chemotherapy, for controlling their symptom experience.

AB - Purpose: This study aimed to investigate symptom experience and identify the predictors of symptom experience in cancer patients undergoing chemotherapy. Method: This study was a cross-sectional and descriptive design. A total of 167 participants were recruited from the outpatient department of a university hospital in South Korea. Symptom experience (symptom prevalence, severity, and interference with daily activities), physiological factors (absolute neutrophil count, hemoglobin), psychological factors (depression, fighting spirit), and a situational factor (social support), based on the Theory of Unpleasant Symptoms, were measured. Descriptive statistics and multiple regression analyses were performed. Results: Symptom prevalence ranged from 74.3% to 98.8% of patients. The five most severe symptoms were fatigue, numbness/tingling, dry mouth, sleep disturbance, and drowsiness. General activity and work were the most affected areas of daily life. Symptom experience was significantly related to hemoglobin, depression, fighting spirit, and social support. In the multiple regression analysis, higher level of depression and lung cancer accounted for 20.2% of the variance in symptom severity. Higher level of depression, lower level of fighting spirit and third or fourth-line chemotherapy accounted for 31.0% of the variance in symptom interference. Conclusions: Attention is drawn to developing a comprehensive approach which considers relevant physiological, psychological and social factors in assessment and management of concurrent symptoms in cancer patients undergoing chemotherapy. Health care professionals need to play a key role in helping patients deal with depressive mood and promote fighting spirit, particularly in patients with lung cancer or patients treated with higher-line chemotherapy, for controlling their symptom experience.

UR - http://www.scopus.com/inward/record.url?scp=84949324291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949324291&partnerID=8YFLogxK

U2 - 10.1016/j.ejon.2015.04.003

DO - 10.1016/j.ejon.2015.04.003

M3 - Article

VL - 19

SP - 644

EP - 653

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

SN - 1462-3889

IS - 6

ER -